BRPI0818340A2 - Produto de dispersão sólida de fármacos baseados em n-aril uréia - Google Patents
Produto de dispersão sólida de fármacos baseados em n-aril uréiaInfo
- Publication number
- BRPI0818340A2 BRPI0818340A2 BRPI0818340A BRPI0818340A2 BR PI0818340 A2 BRPI0818340 A2 BR PI0818340A2 BR PI0818340 A BRPI0818340 A BR PI0818340A BR PI0818340 A2 BRPI0818340 A2 BR PI0818340A2
- Authority
- BR
- Brazil
- Prior art keywords
- based solid
- solid drug
- dispersion product
- drug dispersion
- aryl urea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99961807P | 2007-10-19 | 2007-10-19 | |
| PCT/EP2008/064076 WO2009050291A2 (en) | 2007-10-19 | 2008-10-17 | Solid dispersion product of n-aryl urea-based drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0818340A2 true BRPI0818340A2 (pt) | 2015-04-22 |
Family
ID=40089463
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0818340 BRPI0818340A2 (pt) | 2007-10-19 | 2008-10-17 | Produto de dispersão sólida de fármacos baseados em n-aril uréia |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP2197425A2 (es) |
| JP (1) | JP2011500649A (es) |
| KR (1) | KR20100087170A (es) |
| CN (1) | CN101827584A (es) |
| AU (1) | AU2008313622A1 (es) |
| BR (1) | BRPI0818340A2 (es) |
| CA (1) | CA2699301A1 (es) |
| CO (1) | CO6270206A2 (es) |
| CR (1) | CR11442A (es) |
| DO (1) | DOP2010000117A (es) |
| EC (1) | ECSP10010183A (es) |
| GT (1) | GT201000102A (es) |
| MX (1) | MX2010004291A (es) |
| PA (1) | PA8800101A1 (es) |
| RU (1) | RU2010119929A (es) |
| UA (1) | UA100865C2 (es) |
| WO (1) | WO2009050291A2 (es) |
| ZA (1) | ZA201002095B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009100176A2 (en) * | 2008-02-07 | 2009-08-13 | Abbott Laboratories | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
| JO3002B1 (ar) | 2009-08-28 | 2016-09-05 | Irm Llc | مركبات و تركيبات كمثبطات كيناز بروتين |
| BR112012031516A2 (pt) * | 2010-06-09 | 2016-11-08 | Abbott Lab | dispersões sólidas contendo inibidores de quinase |
| AU2012335663B2 (en) | 2011-11-11 | 2015-12-24 | Array Biopharma Inc. | Method of treating a proliferative disease |
| US9387208B2 (en) | 2011-11-23 | 2016-07-12 | Novartis Ag | Pharmaceutical formulations of (S)-methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate |
| WO2014003678A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil |
| WO2014003677A1 (en) * | 2012-06-28 | 2014-01-03 | Xspray Microparticles Ab | Pharmaceutical compositions comprising solid dispersion particles containing tadalafil |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070104780A1 (en) * | 2005-10-25 | 2007-05-10 | Lipari John M | Formulation comprising a drug of low water solubility and method of use thereof |
| WO2007066189A2 (en) * | 2005-12-09 | 2007-06-14 | Pfizer Products Inc. | Salts, prodrugs and formulations of 1-[5-(4-amino-7-isopropyl-7h-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-2-methoxy-phenyl]-3-(2,4-dichloro-phenyl)-urea |
| AU2007316558A1 (en) * | 2006-11-09 | 2008-05-15 | Abbott Gmbh & Co. Kg | Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor |
-
2008
- 2008-10-17 CN CN200880112150A patent/CN101827584A/zh active Pending
- 2008-10-17 PA PA20088800101A patent/PA8800101A1/es unknown
- 2008-10-17 JP JP2010529408A patent/JP2011500649A/ja active Pending
- 2008-10-17 KR KR1020107010979A patent/KR20100087170A/ko not_active Application Discontinuation
- 2008-10-17 CA CA2699301A patent/CA2699301A1/en not_active Abandoned
- 2008-10-17 EP EP08839333A patent/EP2197425A2/en not_active Withdrawn
- 2008-10-17 BR BRPI0818340 patent/BRPI0818340A2/pt not_active IP Right Cessation
- 2008-10-17 AU AU2008313622A patent/AU2008313622A1/en not_active Abandoned
- 2008-10-17 RU RU2010119929/15A patent/RU2010119929A/ru not_active Application Discontinuation
- 2008-10-17 WO PCT/EP2008/064076 patent/WO2009050291A2/en active Application Filing
- 2008-10-17 UA UAA201006029A patent/UA100865C2/ru unknown
- 2008-10-17 MX MX2010004291A patent/MX2010004291A/es not_active Application Discontinuation
-
2010
- 2010-03-24 ZA ZA2010/02095A patent/ZA201002095B/en unknown
- 2010-04-16 DO DO2010000117A patent/DOP2010000117A/es unknown
- 2010-04-16 GT GT201000102A patent/GT201000102A/es unknown
- 2010-04-27 CO CO10049271A patent/CO6270206A2/es not_active Application Discontinuation
- 2010-05-17 EC EC2010010183A patent/ECSP10010183A/es unknown
- 2010-05-19 CR CR11442A patent/CR11442A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| GT201000102A (es) | 2012-03-12 |
| JP2011500649A (ja) | 2011-01-06 |
| ECSP10010183A (es) | 2010-06-29 |
| CA2699301A1 (en) | 2009-04-23 |
| DOP2010000117A (es) | 2010-05-15 |
| AU2008313622A1 (en) | 2009-04-23 |
| CR11442A (es) | 2010-09-06 |
| UA100865C2 (ru) | 2013-02-11 |
| ZA201002095B (en) | 2011-11-30 |
| PA8800101A1 (es) | 2009-05-15 |
| EP2197425A2 (en) | 2010-06-23 |
| CO6270206A2 (es) | 2011-04-20 |
| WO2009050291A2 (en) | 2009-04-23 |
| WO2009050291A3 (en) | 2010-04-08 |
| KR20100087170A (ko) | 2010-08-03 |
| RU2010119929A (ru) | 2011-11-27 |
| CN101827584A (zh) | 2010-09-08 |
| MX2010004291A (es) | 2010-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2018005I1 (lt) | Farmacinė kompozicija | |
| BRPI0818339A2 (pt) | Produto de dispersão sólida contendo composto à base de n-aril uréia | |
| BRPI0816730A2 (pt) | sistema de distribuição de produto | |
| IL242028A0 (en) | A system for dispensing doses of medicine operated by means of a micro-pump | |
| BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
| BRPI0821876A2 (pt) | Sistemas e métodos para administração de medicação | |
| DK2692341T3 (da) | Misbrugs-resistent lægemiddelformulering | |
| BRPI0812861A2 (pt) | Conexão luer de segurança | |
| BRPI0814639A2 (pt) | Monitor de carregamento | |
| DK2151438T3 (da) | Lægemiddel indeholdende PPAR-Deltaagonist | |
| BRPI0820381A2 (pt) | Formulações farmacêuticas | |
| BRPI0920521A2 (pt) | combinação farmacêutica | |
| BRPI0721651A2 (pt) | Composição farmacêutica | |
| BRPI0817310A2 (pt) | Ensaio de monitoramento de fármaco | |
| BRPI0813753A2 (pt) | Produto pré-impregnado | |
| BRPI0912972A2 (pt) | Produtos lácteos granulados | |
| ATE531278T1 (de) | Süsswaren-produkt | |
| BRPI0919331A2 (pt) | derivados de pirazolo piridina, composições farmacêuticas e métodos associados | |
| DK2120884T3 (da) | Farmaceutisk sammensætning | |
| BRPI0807078A2 (pt) | Composto, e, formulação farmacêutica | |
| BRPI0716883A2 (pt) | Acumulador de produto giratório | |
| BRPI0921654A2 (pt) | formulação farmacêutica | |
| BRPI0912428A2 (pt) | formulação farmacêutica sólida de liberação retardada | |
| BRPI0818340A2 (pt) | Produto de dispersão sólida de fármacos baseados em n-aril uréia | |
| BRPI0922423A2 (pt) | dispositivo de liberação de fármaco |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |